Get an alert when TILLOMED LABORATORIES LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-12-31 (in 7mo)

Last filed for 2025-03-31

Confirmation statement due

2026-10-12 (in 5mo)

Last made up 2025-09-28

Watchouts

None on the register

Cash

£4M

-44% vs 2024

Net assets

£76M

+22.8% vs 2024

Employees

51

0% vs 2024

Profit before tax

£19M

-25.8% vs 2024

Name history

Renamed 1 time since incorporation

  1. TILLOMED LABORATORIES LIMITED 1991-02-20 → present
  2. SCHEMEHOUR LIMITED 1990-09-28 → 1991-02-20

Accounts

2-year trend · latest reflected 2025-03-31

Metric Trend 2024-03-312025-03-31
Turnover £99,222,519£86,263,080
Operating profit £24,734,250£18,111,910
Profit before tax £25,222,826£18,722,738
Net profit £19,009,241£14,056,377
Cash £6,535,557£3,658,248
Total assets less current liabilities £61,642,598£75,698,975
Net assets £61,642,598£75,698,975
Equity £61,642,598£75,698,975
Average employees 5151
Wages £8,539,684£6,770,604

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2024-03-312025-03-31
Operating margin 24.9%21.0%
Net margin 19.2%16.3%
Return on capital employed 40.1%23.9%
Gearing (liabilities / total assets) 21.3%16.8%
Current ratio 4.64x5.90x
Interest cover 171.93x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
MHA Audit Services LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The financial statements have been prepared on a going concern basis. The Directors have considered relevant information... to make their assessment... Based on these assessments and having regard to the resources available to the Company, the Directors have concluded that there is no material uncertainty and that they can continue to adopt the going concern basis in preparing the financial statements.”

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 20 resigned

Name Role Appointed Born Nationality
MEHTA, Samit Satish Director 2018-05-09 Apr 1980 Indian
SHAIKH, Tajuddin Director 2016-11-18 May 1974 Indian
SRIMAL, Ajit Chand Director 2025-01-27 Aug 1958 British
Show 20 resigned officers
Name Role Appointed Resigned
GINAI, Musharaf Mahmood Ahmed Secretary 1994-06-30 1995-12-31
GINAI, Nazma Tasneem Secretary 1995-12-31 2007-03-29
GLICK, Lawrence Secretary 1994-06-30
HIDE, Susan Gaynor Secretary 2017-06-27 2024-10-31
WALTER, Ian Alan Secretary 2007-03-29 2017-06-27
BAER, Rudolf Thomas Director 2024-03-31 2025-01-14
BERZIGOTTI, Massimo Director 2019-10-24 2024-03-31
CAMA, Zarir Jal Director 2018-02-01 2019-05-14
DIXIT, Vineet Kumar Director 2016-11-18 2019-10-16
GINAI, Musharaf Mahmood Ahmed Director 2014-08-27 2016-12-30
GINAI, Musharaf Mahmood Ahmed Director 2014-05-07
GLICK, Lawrence Director 1994-06-30
JONES, David Graham Director 1996-01-01
MEHTA, Samit Satish Director 2014-05-07 2016-11-18
MEHTA, Satish Ramanlal Director 2014-05-07 2017-07-20
SAPTE, Vinay Director 2007-03-29 2014-05-08
SNYCKERS, Hugo Director 1996-01-01
SRIMAL, Ajit Chand Director 2017-07-20 2020-03-31
STANFORD, Steven Roy Director 1992-01-01 1996-01-01
THAPAR, Vikas Director 2014-05-07 2016-11-25

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Emcure Pharma Uk Ltd Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2018-12-04 Active
Tillomed Holdings Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2016-04-06 Ceased 2018-12-04
Emcure Pharmaceuticals Limited Corporate entity Shares 75–100% 2016-04-06 Ceased 2016-04-06

Filing timeline

Last 20 of 178 total filings

Date Type Category Description
2025-10-13 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-07-14 AA accounts Accounts with accounts type full
2025-02-26 TM01 officers Termination director company with name termination date PDF
2025-02-26 AP01 officers Appoint person director company with name date PDF
2024-10-31 TM02 officers Termination secretary company with name termination date PDF
2024-10-22 AA accounts Accounts with accounts type full
2024-10-08 MR04 mortgage Mortgage satisfy charge full PDF
2024-10-08 MR04 mortgage Mortgage satisfy charge full PDF
2024-10-03 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-04-08 AP01 officers Appoint person director company with name date PDF
2024-04-08 TM01 officers Termination director company with name termination date PDF
2024-01-15 MR01 mortgage Mortgage create with deed with charge number charge creation date PDF
2023-12-04 MR04 mortgage Mortgage satisfy charge full PDF
2023-10-24 AA accounts Accounts with accounts type full
2023-10-19 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-10-04 MR01 mortgage Mortgage create with deed with charge number charge creation date PDF
2023-09-19 MR01 mortgage Mortgage create with deed with charge number charge creation date PDF
2023-09-15 MR01 mortgage Mortgage create with deed with charge number charge creation date PDF
2023-08-15 MR04 mortgage Mortgage satisfy charge full PDF
2022-10-11 CS01 confirmation-statement Confirmation statement with no updates PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
2

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page